Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

SHE:002940 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	6,307	2,632	4,377	3,684	3,486	3,968
Market Cap Growth	134.45%	-39.86%	18.80%	5.68%	-12.16%	47.37%
Enterprise Value	6,218	2,582	4,255	3,430	2,877	3,421
Last Close Price	32.16	13.11	21.30	18.11	16.64	18.68
PE Ratio	59.64	32.77	31.63	28.94	29.09	24.24
PS Ratio	4.36	1.74	2.70	2.35	2.53	3.08
PB Ratio	3.45	1.46	2.39	2.24	2.36	2.88
P/TBV Ratio	5.46	2.43	3.86	2.56	2.73	3.10
P/FCF Ratio	43.51	16.54	28.80	31.78	31.59	36.86
P/OCF Ratio	32.97	10.38	15.81	19.94	17.64	19.98
EV/Sales Ratio	4.30	1.71	2.63	2.19	2.08	2.65
EV/EBITDA Ratio	30.12	12.58	17.65	16.91	14.56	16.80
EV/EBIT Ratio	55.48	21.81	26.00	24.19	19.02	21.12
EV/FCF Ratio	42.89	16.23	28.00	29.59	26.07	31.78
Debt / Equity Ratio	0.26	0.27	0.32	0.21	0.00	0.01
Debt / EBITDA Ratio	2.27	2.37	2.43	1.71	0.01	0.06
Debt / FCF Ratio	3.23	3.06	3.88	2.99	0.02	0.11
Asset Turnover	0.48	0.51	0.58	0.67	0.69	0.78
Inventory Turnover	1.89	2.06	2.66	2.28	1.74	1.60
Quick Ratio	1.27	1.16	1.55	1.40	1.79	2.06
Current Ratio	1.90	1.78	2.13	1.84	2.31	2.56
Return on Equity (ROE)	8.06%	8.37%	10.53%	8.46%	9.91%	15.14%
Return on Assets (ROA)	2.33%	2.47%	3.64%	3.79%	4.70%	6.09%
Return on Invested Capital (ROIC)	6.57%	7.31%	10.55%	13.29%	19.59%	30.09%
Return on Capital Employed (ROCE)	5.20%	5.60%	7.20%	7.80%	10.20%	11.60%
Earnings Yield	1.71%	3.05%	3.16%	3.46%	3.44%	4.13%
FCF Yield	2.30%	6.05%	3.47%	3.15%	3.16%	2.71%
Dividend Yield	0.63%	0.95%	0.99%	1.14%	0.86%	1.27%
Payout Ratio	95.09%	73.15%	44.53%	26.83%	39.27%	55.01%
Buyback Yield / Dilution	-1.31%	-0.15%	-0.82%	0.42%	-5.03%	-0.70%
Total Shareholder Return	-0.69%	0.81%	0.16%	1.56%	-4.17%	0.57%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.